References
- TaylorCPAngelottiTFaumanEPharmacology and mechanism of action of pregabalin: the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discoveryEpilepsy Res200773213715017126531
- DooleyDJDonovanCMPugsleyTAStimulus-dependent modulation of [(3)H] norepinephrine release from rat neocortical slices by gabapentin and pregabalinJ Pharmacol Exp Ther200029531086109311082444
- FinkKDooleyDJMederWPInhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortexNeuropharmacology200242222923611804619
- MichevaKDTaylorCPSmithSJPregabalin reduces the release of synaptic vesicle form cultured hippocampal neuronsMol Pharmacol200670246747616641316
- BockbraderHNRadulovicLLPosvarELClinical pharmacokinet-ics of pregabalin in healthy volunteersJ Clin Pharmacol201050894195020147618
- BockbraderHNBurgerPKnappLCorriganBWPopulation pharma-cokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizuresEpilepsia201152224825721269291
- ShojiSSuzukiMTomonoYBockbraderHNMatsuiSPopulation pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathyBr J Clin Pharmacol2011721637621306415
- OlesenAEOlofsenEOlesenSSThe absorption profile of pregaba-lin in chronic pancreatitisBasic Clin Pharmacol Toxicol2012111638539022716224
- VaidyaVVYetalSMRoySMGomesNAJoshiSSLC-MS-MS determination of pregabalin in human plasmaChromatographia20076611925928
- BoeckmannASheinerLBealSNONMEM User’s Guide – Part V, Introductory GuideSan Francisco, CANONMEM Project Group, University of California at San Francisco2013
- RousseauALégerFLe MeurYPopulation pharmacokinetic modeling of oral cyclosporine using NONMEMTher Drug Monit2004261233014749545
- SavicRMJonkerDMKerbuschTKarlssonMOImplementation of a transit compartment model for describing drug absorption in pharmacokinetic studiesJ Pharmacokinet Pharmacodyn200734571172617653836
- PetricoulOCossonVFuseauEMarchandMPopulation models for drug absorption and enterohepatic recyclingEtteEIWilliamsPJPharmacometrics: The Science of Quantitative PharmacologyHoboken, NJJohn Wiley & Sons, Inc2007345382
- ShenJBoeckmannAVickAImplementation of dose superimposition to introduce multiple doses for a mathematical absorption model (transit compartment model)J Pharmacokinet Pharmacodyn201239325126222555854
- PaiMPPaloucekFPThe origin of the “ideal” body weight equationsAnn Pharmacother20003491066106910981254
- CockcroftDWGaultMHPrediction of creatinine clearance from serum creatinineNephron197616131411244564
- BuvanendranAKroinJSKariMTumanKJCan a single dose of 300 mg of pregabalin reach acute antihyperalgesic levels in the central nervous system?Reg Anesth Pain Med201035653553820975469
- BenderGFlorianJAJrBramwellSPharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic painJ Pharmacol Exp Ther2010334259960820444880
- SemelDMurphyTKZlatevaGCheungREmirBEvaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesBMC Fam Pract2010118521054853
- WilkinsJJSavicRMKarlssonMOPopulation pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semi-mechanistic model to describe variable absorptionAntimicrob Agents Chemother20085262138214818391026